45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
8,115
Insurances with rates
9
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
437790
$145,137
ipilimumab 5 mg/mL 40 mL [MDIH]
Gross
$161,264
438145
$79,843
ocrelizumab 300 mg/10 mL [MDIH]
Gross
$88,715
436183
$65,439
rabies immune globulin, human 300 intl units/mL (5 mL) [MDIH]
Gross
$72,710
13227490
$61,976
cabazitaxel 60 mg/1.5 mL Sol [MDIH]
Gross
$68,863
10067963
$55,229
paliperidone 1092 mg/3.5 mL Sus [MDIH]
Gross
$61,366
439013
$52,473
luspatercept-aamt 75 mg Pow [MDIH]
Gross
$58,304
437781
$48,062
brentuximab vedotin 50 mg Pow [MDIH]
Gross
$53,402
12147409
$46,831
dostarlimab-gxly 500 mg/10 mL Sol [MDIH]
Gross
$52,034
11811057
$43,693
leuprolide pediatric 11.25 mg/3 months Kit [MDIH]
Gross
$48,548
12124313
$41,706
cemiplimab-rwlc 350 mg/7 mL Sol [MDIH]
Gross
$46,340
13372793
$41,293
gemtuzumab ozogamicin 4.5 mg Pow[MDIH]
Gross
$45,881
12367516
$40,985
risankizumab rzaa 600mg/ 10mL Sol [MDIH]
Gross
$45,539
11555787
$39,836
paliperidone 819 mg/2.63 mL Sus [MDIH]
Gross
$44,262
439231
$39,061
daratumumab-hyaluronidase 1800 mg-30,000 units/15 mL [MDIH]
Gross
$43,401
437789
$36,284
ipilimumab 5 mg/mL 10 mL [MDIH]
Gross
$40,316
436771
$35,100
vedolizumab 300 mg Pow [MDIH]
Gross
$39,000
433154
$34,212
alteplase 100 mg IV Inj [MDIH]
Gross
$38,014
437822
$33,379
obinutuzumab 25 mg/mL (40 mL) [MDIH]
Gross
$37,088
435785
$33,248
natalizumab 300 mg/15 mL IV Conc [MDIH]
Gross
$36,942
13301978
$32,186
tenecteplase 25 mg Pow [MDIH]
Gross
$35,762
13157286
$32,186
tenecteplase 50 mg Pow [MDIH]
Gross
$35,762
437883
$31,830
nivolumab 10 mg/mL 24 mL [MDIH]
Gross
$35,366
12931905
$30,684
olipudase alfa rpcp 20 mg Pow
Gross
$34,093
435437
$29,544
tenecteplase 50 mg IV Inj [MDIH]
Gross
$32,827
439647
$28,366
ramucirumab 10 mg/mL (50 mL) Sol [MDIH]
Gross
$31,518
10499359
$27,729
PULSAVAC PLUS FAN KIT
Gross
$30,810
438539
$27,250
panitumumab 20 mg/mL IV Sol 20 mL [MDIH]
Gross
$30,277
9671275
$26,924
octreotide 30 mg IM Inj [MDIH]
Gross
$29,915
12744896
$26,711
VENTIX LINK 4.75MM DISP DRILL
Gross
$29,679
436710
$26,667
collagenase clostridium histolyticum 0.9 mg Pow [MDIH]
Gross
$29,630
439123
$26,507
paliperidone 546 mg/1.75 mL [MDIH]
Gross
$29,453
436977
$26,433
pertuzumab 420 mg/14 mL [MDIH]
Gross
$29,371
436349
$25,219
ado-trastuzumab emtansine 160 mg Pow [MDIH]
Gross
$28,021
13043964
$25,071
efgartigimod alfa fcab 400 mg/20 mL Sol
Gross
$27,857
12866723
$24,656
lanreotide 60 mg/0.2 mL Sol [MDIH]
Gross
$27,396
437905
$24,492
lanreotide 120 mg/0.5 mL SC Sol [MDIH]
Gross
$27,213
9934481
$24,308
X RX BAG NACL .9P 500ML
Gross
$27,009
9842187
$24,308
X RX BOTTLE STERILE WATER FOR IRRIG
Gross
$27,009
438983
$23,526
ixabepilone 45 mg IV Inj [MDIH]
Gross
$26,140
437324
$22,958
pembrolizumab 25 mg/mL [MDIH]
Gross
$25,509
437501
$22,891
golimumab 50 mg/0.5 mL [MDIH]
Gross
$25,434
439098
$22,822
ustekinumab 90 mg/mL [MDIH]
Gross
$25,358
12215848
$22,368
pegfilgrastim 6 mg / 0.6 mL OnBody [MDIH]
Gross
$24,854
438567
$22,245
certolizumab 200 mg/mL Kit [MDIH]
Gross
$24,717
438625
$21,235
romiPLOStim 500 mcg Pow [MDIH]
Gross
$23,595
9843296
$20,897
PSN TIB STM 5 DEG SZ E L
Gross
$23,219
438316
$20,347
benralizumab 30 mg/mL [MDIH]
Gross
$22,608
436083
$19,025
riTUXimab 10 mg/mL IV Sol 50 mL [MDIH]
Gross
$21,139
439361
$18,935
trastuzumab-hyalyuronidase-oysk 600 mg-10,000 units/5 mL Inj [MDIH]
Gross
$21,039
9843257
$18,698
PSN ASF CR 12MM VE L 3-9 CD
Gross
$20,776
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 437790 | ipilimumab 5 mg/mL 40 mL [MDIH] | $161,264 | $145,137 | — | — | 10 |
| 438145 | ocrelizumab 300 mg/10 mL [MDIH] | $88,715 | $79,843 | — | — | 10 |
| 436183 | rabies immune globulin, human 300 intl units/mL (5 mL) [MDIH] | $72,710 | $65,439 | — | — | 10 |
| 13227490 | cabazitaxel 60 mg/1.5 mL Sol [MDIH] | $68,863 | $61,976 | — | — | 10 |
| 10067963 | paliperidone 1092 mg/3.5 mL Sus [MDIH] | $61,366 | $55,229 | — | — | 10 |
| 439013 | luspatercept-aamt 75 mg Pow [MDIH] | $58,304 | $52,473 | — | — | 10 |
| 437781 | brentuximab vedotin 50 mg Pow [MDIH] | $53,402 | $48,062 | — | — | 10 |
| 12147409 | dostarlimab-gxly 500 mg/10 mL Sol [MDIH] | $52,034 | $46,831 | — | — | 10 |
| 11811057 | leuprolide pediatric 11.25 mg/3 months Kit [MDIH] | $48,548 | $43,693 | — | — | 10 |
| 12124313 | cemiplimab-rwlc 350 mg/7 mL Sol [MDIH] | $46,340 | $41,706 | — | — | 10 |
| 13372793 | gemtuzumab ozogamicin 4.5 mg Pow[MDIH] | $45,881 | $41,293 | — | — | 10 |
| 12367516 | risankizumab rzaa 600mg/ 10mL Sol [MDIH] | $45,539 | $40,985 | — | — | 10 |
| 11555787 | paliperidone 819 mg/2.63 mL Sus [MDIH] | $44,262 | $39,836 | — | — | 10 |
| 439231 | daratumumab-hyaluronidase 1800 mg-30,000 units/15 mL [MDIH] | $43,401 | $39,061 | — | — | 10 |
| 437789 | ipilimumab 5 mg/mL 10 mL [MDIH] | $40,316 | $36,284 | — | — | 10 |
| 436771 | vedolizumab 300 mg Pow [MDIH] | $39,000 | $35,100 | — | — | 10 |
| 433154 | alteplase 100 mg IV Inj [MDIH] | $38,014 | $34,212 | — | — | 10 |
| 437822 | obinutuzumab 25 mg/mL (40 mL) [MDIH] | $37,088 | $33,379 | — | — | 10 |
| 435785 | natalizumab 300 mg/15 mL IV Conc [MDIH] | $36,942 | $33,248 | — | — | 10 |
| 13301978 | tenecteplase 25 mg Pow [MDIH] | $35,762 | $32,186 | — | — | 10 |
| 13157286 | tenecteplase 50 mg Pow [MDIH] | $35,762 | $32,186 | — | — | 10 |
| 437883 | nivolumab 10 mg/mL 24 mL [MDIH] | $35,366 | $31,830 | — | — | 10 |
| 12931905 | olipudase alfa rpcp 20 mg Pow | $34,093 | $30,684 | — | — | 10 |
| 435437 | tenecteplase 50 mg IV Inj [MDIH] | $32,827 | $29,544 | — | — | 10 |
| 439647 | ramucirumab 10 mg/mL (50 mL) Sol [MDIH] | $31,518 | $28,366 | — | — | 10 |
| 10499359 | PULSAVAC PLUS FAN KIT | $30,810 | $27,729 | — | — | 14 |
| 438539 | panitumumab 20 mg/mL IV Sol 20 mL [MDIH] | $30,277 | $27,250 | — | — | 10 |
| 9671275 | octreotide 30 mg IM Inj [MDIH] | $29,915 | $26,924 | — | — | 10 |
| 12744896 | VENTIX LINK 4.75MM DISP DRILL | $29,679 | $26,711 | — | — | 14 |
| 436710 | collagenase clostridium histolyticum 0.9 mg Pow [MDIH] | $29,630 | $26,667 | — | — | 10 |
| 439123 | paliperidone 546 mg/1.75 mL [MDIH] | $29,453 | $26,507 | — | — | 10 |
| 436977 | pertuzumab 420 mg/14 mL [MDIH] | $29,371 | $26,433 | — | — | 10 |
| 436349 | ado-trastuzumab emtansine 160 mg Pow [MDIH] | $28,021 | $25,219 | — | — | 10 |
| 13043964 | efgartigimod alfa fcab 400 mg/20 mL Sol | $27,857 | $25,071 | — | — | 10 |
| 12866723 | lanreotide 60 mg/0.2 mL Sol [MDIH] | $27,396 | $24,656 | — | — | 10 |
| 437905 | lanreotide 120 mg/0.5 mL SC Sol [MDIH] | $27,213 | $24,492 | — | — | 10 |
| 9934481 | X RX BAG NACL .9P 500ML | $27,009 | $24,308 | — | — | 14 |
| 9842187 | X RX BOTTLE STERILE WATER FOR IRRIG | $27,009 | $24,308 | — | — | 14 |
| 438983 | ixabepilone 45 mg IV Inj [MDIH] | $26,140 | $23,526 | — | — | 10 |
| 437324 | pembrolizumab 25 mg/mL [MDIH] | $25,509 | $22,958 | — | — | 20 |
| 437501 | golimumab 50 mg/0.5 mL [MDIH] | $25,434 | $22,891 | — | — | 10 |
| 439098 | ustekinumab 90 mg/mL [MDIH] | $25,358 | $22,822 | — | — | 10 |
| 12215848 | pegfilgrastim 6 mg / 0.6 mL OnBody [MDIH] | $24,854 | $22,368 | — | — | 10 |
| 438567 | certolizumab 200 mg/mL Kit [MDIH] | $24,717 | $22,245 | — | — | 10 |
| 438625 | romiPLOStim 500 mcg Pow [MDIH] | $23,595 | $21,235 | — | — | 10 |
| 9843296 | PSN TIB STM 5 DEG SZ E L | $23,219 | $20,897 | — | — | 14 |
| 438316 | benralizumab 30 mg/mL [MDIH] | $22,608 | $20,347 | — | — | 10 |
| 436083 | riTUXimab 10 mg/mL IV Sol 50 mL [MDIH] | $21,139 | $19,025 | — | — | 10 |
| 439361 | trastuzumab-hyalyuronidase-oysk 600 mg-10,000 units/5 mL Inj [MDIH] | $21,039 | $18,935 | — | — | 10 |
| 9843257 | PSN ASF CR 12MM VE L 3-9 CD | $20,776 | $18,698 | — | — | 14 |
Showing top 50 of 8,115 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.